News
Merck, through a subsidiary, will acquire Verona Pharma for a total transaction value of approximately $10 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback